Functional consequences of reduced retinoic acid receptor γ expression in a human squamous cell carcinoma line

Molecular Pharmacology

Volumn 51, Issue 3, 1997, Pages 377-382

  Monzon, Ricardo I ^a   Fillmore, Catherine ^a   Hudson, Laurie G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INVOLUCRIN; MESSENGER RNA; RECEPTOR SUBTYPE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; GENE EXPRESSION; HUMANS; KERATINOCYTES; LIGANDS; PROTEIN PRECURSORS; RECEPTORS, RETINOIC ACID; TRANSCRIPTION, GENETIC; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

EID: 0030974512     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lohnes, D., M. Mark, C. Mendelsohn, P. Dolle, D. Decimo, M. LeMeur, A. Dierich, P. Gorry, and P. Chambon. Developmental roles of the retinoic acid receptors. J. Steroid Biochem. Mol. Biol. 53:475-486 (1995).
2. Gudas, L. J. Retinoids and vertebrate development. J. Biol. Chem. 269: 15399-15402 (1994).
3. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev. 15:61-79 (1994).
4. Fuchs, E., and C. Byrne. The epidermis: rising to the surface. Curr. Opin. Genet. Dev. 4:725-736 (1994).
5. Lotan, R. M. Squamous differentiation and retinoids, in Head and Neck Cancer (W. K. Hong and R. S. Weber, eds.). Kluwer Academic Publishers, Norwell, MA, 43-72 (1995).
6. Fisher, G. J., H. S. Talwar, J. H. Xiao, S. C. Datta, A. P. Reddy, M. P. Gaub, C. Rochette-Egly, P. Chambon, and J. J. Voorhees. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J. Biol. Chem. 269:20629-20635 (1994).
7. Saitou, M., S. Sugai, T. Tanaka, K. Shimouchi, E. Fuchs, S. Narumiya, and A. Kakizuka. Inhibition of skin development by targeted expression of a dominant negative retinoic acid receptor. Nature (Lond.) 374:159-162 (1995).
8. Imakado, S., J. R. Bickenbach, D. S. Bundman, J. A. Rothagel, P. S. Attar, X. J. Wang, V. R. Walczak, S. Wisniewski, J. Pote, J. S. Gordon, R. A. Heyman, R. M. Evans, and D. R. Roop. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 9:317-329 (1995).
9. Aneskievich, B. J., and E. Fuchs. The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy. J. Cell Sci. 108:195-205 (1995).
10. Houle, B., M. Pelletier, J. Wu, C. Goodyer, and W. E. C. Bradley. Fetal isoform of human retinoid acid receptor beta expressed in small cell lung cancer lines. Cancer Res. 54:365-369 (1994).
11. Xu, X., J. Ro, J. Lee, D. Shin, W. Hong, and R. Lotan. Differential expression of nuclear retinoid receptors in normal, premalignant and malignant head and neck tissues. Cancer Res. 54:3580-3587 (1994).
12. Houle, B., C. Rochette-Egly, and W. E. C. Bradley. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA 90:985-989 (1993).
13. Crowe, D. L., L. Hu, L. J. Gudas, and J. G. Rheinwald. Variable expression of retinoic acid receptor beta mRNA in human oral and epidermal keratinocytes: relation to keratin 19 expression and keratinization potential. Differentiation 48:199-208 (1991).
14. Hu, L., D. Crowe, J. Rheinwald, P. Chambon, and L. Gudas. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51:3972-3981 (1991).
15. Lotan, R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res. 54:1987S-1990S (1994).
16. Darwiche, N., G. Celli, T. Tennenbaum, A. B. Glick, S. H. Yuspa, and L. M. De Luca Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 55:2774-2782 (1995).
17. Ponec, M., A. Weerheim, J. Kempenaar, and J. Boonstra. Proliferation and differentiation of human squamous carcinoma cell lines and normal keratinocytes: effects of epidermal growth factor, retinoids and hydrocortisone. In Vitro Cell. Dev. Biol. 24:764-770 (1988).
18. Rubin, A., and R. Rice. Differential regulation by retinoic acid and calcium of transglutaminases in cultured neoplastic and normal human keratinocytes. Cancer Res. 46:2356-2361 (1986).
19. Breitkreutz, D., H. J. Startk, P. Plein, M. Baur, and N. E. Fusenig. Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular calcium. Differentiation 54:201-217 (1993).
20. Lotan, R. Squamous cell differentiation markers in normal, premalignant and malignant epithelium: effects of retinoids. J. Cell. Biochem. 17F:167-174 (1993).
21. Rheinwald, J. G., and M. A. Beckett. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22:629-632 (1980).
22. Monzon, R. I., J. J. LaPres, and L. G. Hudson. Regulation of involucrin gene expression by retinoic acid and glucocorticoids. Cell Growth Differ. 7:1751-1759 (1996).
23. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. Current Protocols in Molecular Biology. John Wiley & Sons, New York (1989).
24. Eckert R. L., and H. Green. Structure and evolution of the human involucrin gene. Cell 46:583-589 (1986).
25. Petkovich, M., N. J. Brand, A. Krust, and P. Chambon. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.) 330:444-450 (1987).
26. Krust, A., P. Kastner, M. Petkovich, A. Zelent, and P. Chambon. A third human retinoic acid receptor, RAR gamma. Proc. Natl. Acad. Sci. USA 86:5310-5314 (1989).
27. Ferrari, N., U. Pfeffer, F. Tosetti, C. Brigati, and G. Vidali. An improved RT-PCR protocol for the quantitation of human retinoic acid receptor RNA. Exp. Cell Res. 211:121-126 (1994).
28. Ercolani, L., B. Florence, M. Denaro, and M. Alexander. Isolation and complete sequence of a functional glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263:15335-15341 (1988).
29. LaPres, J. J., and L. G. Hudson. Identification of a functional determinant of differentiation dependent expression in the involucrin gene. J. Biol. Chem. 271:23154-23160 (1996).
30. Hudson, L. G., J. B. Santon, C. K. Glass, and G. N. Gill. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 62:1165-1175 (1990).
31. Eckert, R. L., M. B. Yaffe, J. F. Crish, S. Murthy, E. A. Rorke, and J. F. Welter. Involucrin - structure and role in envelope assembly. J. Invest. Dermatol. 100:613-617 (1993).
32. Welter, J. F., J. F. Crish, C. Agarwal, and R. L. Eckert. Fos-related antigen (Fra-1), junB and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects and promoter activity. J. Biol. Chem. 270:12614-12622 (1995).
33. Gudas, L. J. Retinoids, retinoid-responsive genes, cell differentiation and cancer. Cell Growth Differ. 3:655-662 (1992).
34. Boylan, J. F., D. Lohnes, R. Taneja, P. Chambon, and L. J. Gudas. Loss of RARγ function by gene disruption results in aberrant hoxa-1 expression and differentiation upon retinoic acid treatment. Proc. Natl. Acad. Sci. USA 90:9601-9605 (1993).
35. Boylan, J. F., T. Lufkin, C. C. Achkar, R. Taneja, P. Chambon, and L. J. Gudas. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor specific alterations in retinoic acid mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 15:843-851 (1995).
36. Taneja, R., P. Bouillet, J. F. Boylan, M.-P. Gaub, B. Roy, L. J. Gudas, and P. Chambon. Reexpression of retinoic acid receptor (RAR)γ or over-expression of RARα or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Natl. Acad. Sci. USA 92:7854-7858 (1995).
37. Chen, S., J. Ostrowski, G. Whiting, T. Roalsvig, L. Hammer, S. J. Currier, J. Honeyman, B. Kwasniewski, K.-L. Yu, R. Sterzycki, C. U. Kim, J. Starret, M. Mansuri, and P. R. Reczek. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J. Invest. Dermatol. 104:779-783 (1995).
38. Oridate, N., N. Esumi, D. Lotan, W. K. Hong, C. Rochette-Egly, P. Chambon, and R. Lotan. Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cell. Oncogene 12:2019-2028 (1996).
39. Glass, C. K. Differential recognition of target genes by nuclear receptor monomers, dimers and heteromers. Endocr. Rev. 15:391-407 (1994).
40. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. A CBP integrator complex mediates transcriptional activation and AP1 inhibition by nuclear receptors. Cell 85:403-414 (1996).